- £26.59m
- £22.22m
- £9.27m
- 77
- 43
- 95
- 86
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 6.42 | 6.41 | 9.45 | 9.31 | 9.27 |
Cost of Revenue | |||||
Gross Profit | 5.1 | 5.27 | 8.16 | 7.71 | 7.69 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 4.81 | 4.89 | 6.22 | 6.84 | 7.17 |
Operating Profit | 1.6 | 1.51 | 3.23 | 2.47 | 2.1 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 1.63 | 1.53 | 3.21 | 2.47 | 2.15 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1.31 | 1.24 | 2.61 | 1.98 | 1.68 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 1.28 | 1.17 | 2.52 | 1.95 | 1.67 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 1.28 | 1.17 | 2.52 | 1.95 | 1.67 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.097 | 0.084 | 0.195 | 0.152 | 0.115 |
Dividends per Share | |||||
Special Dividends per Share |